196 related articles for article (PubMed ID: 7961285)
1. Cytochemistry and immunochemistry in hematologic diagnoses.
Li CY; Yam LT
Hematol Oncol Clin North Am; 1994 Aug; 8(4):665-81. PubMed ID: 7961285
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive bone marrow diagnosis on a single aspiration sample. Plastic sections and cell suspensions for enzyme and immunohisto- and cytochemistry.
van de Sandt MM; Herman CJ; Lindeman J
Pathol Annu; 1987; 22 Pt 1():67-82. PubMed ID: 3554122
[No Abstract] [Full Text] [Related]
3. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
Orazi A
Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
[TBL] [Abstract][Full Text] [Related]
4. [Cytochemical stains of value in hematological diagnosis].
Lagerlöf B; Sundström C; Ost A
Lakartidningen; 1979 Dec; 76(49):4495-8. PubMed ID: 94646
[No Abstract] [Full Text] [Related]
5. Physician Education: Myelodysplastic Syndrome.
Yoshida Y
Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications of molecular haematology: flow cytometry in leukaemias and myelodysplastic syndromes.
Dalal BI
J Assoc Physicians India; 2007 Aug; 55():571-3. PubMed ID: 18019799
[TBL] [Abstract][Full Text] [Related]
7. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
[TBL] [Abstract][Full Text] [Related]
8. [Testing the hemalog D in a hematology department of a general hospital in Paris (author's transl)].
Lortholary P; Lejeune F; Ganon JP; Mathiot C; Turpin F
Nouv Rev Fr Hematol (1978); 1978 Jun; 20(2):223-48. PubMed ID: 279890
[TBL] [Abstract][Full Text] [Related]
9. The role of cytology, cytochemistry, immunophenotyping and cytogenetic analysis in the diagnosis of haematological neoplasms. General Haematology Task Force of the BCSH.
Clin Lab Haematol; 1996 Dec; 18(4):231-6. PubMed ID: 9054693
[TBL] [Abstract][Full Text] [Related]
10. Cytochemistry and immunocytochemistry in bone marrow examination: contemporary techniques for the diagnosis of acute leukemia and myelodysplastic syndromes. A combined approach.
Kass L; Elias JM
Hematol Oncol Clin North Am; 1988 Dec; 2(4):537-55. PubMed ID: 3065317
[TBL] [Abstract][Full Text] [Related]
11. [Contribution of a hematologic cytogenetic laboratory to the diagnosis, classification and prognosis of various hematologic malignancies].
Debray J; Krulik M; Smadja NV
Bull Acad Natl Med; 1992 May; 176(5):629-38; discussion 638-40. PubMed ID: 1422868
[TBL] [Abstract][Full Text] [Related]
12. [Importance of cytochemical studies in the diagnosis of diseases of the white blood cell system].
Kowalska H
Wiad Lek; 1971 Aug; 24(16):1537-42. PubMed ID: 4940131
[No Abstract] [Full Text] [Related]
13. [Diagnosis of myeloid hematologic malignancies: contributions of the 2001 World Health Organization (WHO) classification].
Leymarie V; Galoisy AC; Falkenrodt A; Lessard M
Ann Biol Clin (Paris); 2004; 62(5):513-20. PubMed ID: 15355801
[TBL] [Abstract][Full Text] [Related]
14. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
[TBL] [Abstract][Full Text] [Related]
15. [Clinical importance of karyotype in hematology].
Bellomo MJ
Schweiz Med Wochenschr; 1994 Jan; 124(1-2):26-36. PubMed ID: 8296188
[TBL] [Abstract][Full Text] [Related]
16. [Lysozyme in hematologic diseases].
Zittoun J; Zittoun R
Sem Hop; 1975 Jan; 51(4):247-52. PubMed ID: 167445
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotype in chronic myelomonocytic leukemia: is it closer to myelodysplastic syndromes or to myeloproliferative disorders?
Subirá D; Font P; Villalón L; Serrano C; Askari E; Góngora E; Castañón S; Gonzalo R; Mata R; Román A; Llamas P
Transl Res; 2008 May; 151(5):240-5. PubMed ID: 18433705
[TBL] [Abstract][Full Text] [Related]
18. Transient myeloproliferative disorder (transient leukemia) and hematologic manifestations of Down syndrome.
Zipursky A; Brown EJ; Christensen H; Doyle J
Clin Lab Med; 1999 Mar; 19(1):157-67, vii. PubMed ID: 10403079
[TBL] [Abstract][Full Text] [Related]
19. Acute leukemias: a paradigm for the integration of new technologies in diagnosis and classification.
Willman CL
Mod Pathol; 1999 Feb; 12(2):218-28. PubMed ID: 10071344
[TBL] [Abstract][Full Text] [Related]
20. [Histopathology and molecular pathology of chronic myeloproliferative disorders].
Kreipe HH
Veroff Pathol; 1993; 141():1-158. PubMed ID: 8372486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
